🔴 MEDP is trading 11.9% down today as shares adjust after recent volatility and growth concerns

MEDP is trading 11.9% down at $479 in pre-market as shares adjust after recent volatility and growth-deceleration concerns.

• The decline gives back a portion of the stock's sharp rebound over the past week, with no fresh company-specific news or rating changes reported this morning.
• Investors remain focused on previously reported growth-deceleration concerns ahead of the company's Q2 earnings report scheduled for July 22, 2026.